The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3

Title
The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3
Authors
Keywords
Tuberculosis, HIV, Vaccines, Safety, Immunogenicity, DOH-27-0809-2497, Clinicaltrials.gov (NHREC no. NCT01017536)
Journal
VACCINE
Volume 33, Issue 15, Pages 1890-1896
Publisher
Elsevier BV
Online
2015-02-17
DOI
10.1016/j.vaccine.2015.02.004

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started